PT002/#568 Cadonilimab in Combination with Disitamab Vedotin or Nab-Paclitaxel in the Treatment of Recurrent or Metastatic Cervical Cancer: a Prospective, Double-Cohort, Multi-Center, Open-Label, Phase II Clinical Study (AK001)
International Journal of Gynecological Cancer（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined